Trials / Completed
CompletedNCT06393621
Investigate the Effectiveness of KEFPEP® on Regulating High Blood Pressure
Prospective, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Investigate the Effectiveness of KEFPEP® on Regulating High Blood Pressure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- National Chung Hsing University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
To assess the ability of KEFPEP® to reduce blood pressure
Detailed description
Primary objective- • To assess the ability of KEFPEP® to reduce blood pressure. Secondary objective- 1. To access the effect of KEFPEP® on vascular inflammation or damage. 2. To access the effect of KEFPEP® on cardiovascular diseases prevention. 3. To assess the safety of KEFPEP® .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | KEFPEP® | Twice daily (one pack before breakfast and the other before dinner) |
| OTHER | Placebo | Twice daily (one pack before breakfast and the other before dinner) |
Timeline
- Start date
- 2018-07-26
- Primary completion
- 2023-04-18
- Completion
- 2023-08-28
- First posted
- 2024-05-01
- Last updated
- 2024-05-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06393621. Inclusion in this directory is not an endorsement.